ArfGAP with GTPase domain, ankyrin repeat and PH domain 14, pseudogene (AGAP14P)

AGAP14P is annotated as a pseudogene in the human genome and is not believed to encode a functional protein. It is related to the ArfGAP subfamily (Arf GTPase-activating proteins), which generally function in membrane trafficking and actin cytoskeletal regulation, but AGAP14P itself does not encode a product with these functions[2][4]. AGAP protein family members, when functional, contain Arf GAP, GTPase-like, ankyrin repeat, and PH (pleckstrin homology) domains[1]. However, AGAP14P is not known to be functional and has no evidence of being involved as a therapeutic target, in disease processes, or as a molecular biomarker. There is no information available linking it to drug interactions, pharmacology, or clinical challenges. Summary of main issues: - AGAP14P is a pseudogene, meaning it is not expressed as a functional protein and does not perform canonical biological functions, nor does it have therapeutic relevance as a target[2][4]. - The presence of "pseudogene" in its name and annotation, with supporting evidence from major gene databases, indicates it should not be considered a real molecular target for drug discovery or clinical intervention. - No literature describes a disease implication, functional assays, biomarkers, or safety concerns related to AGAP14P. If you intended to obtain information about a functional protein from the AGAP family (e.g., AGAP1, AGAP2), those do have more established biological roles and can be explored separately[1]. AGAP14P specifically, however, is best classified as a non-functional genomic locus.

Other names

bA145E20.1Centaurin, gamma-like family, member 11 pseudogeneCTGLF11PAGAP14ArfGAP with GTPase domain, ankyrin repeat and PH domain 14Putative centaurin-gamma-like family member 11P[4]